Nurse Practitioner, Family · Forest Hills, NY
NPI
1689115065
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
10816 72nd Ave Ste 2
Forest Hills, NY, 11375
Phone (347) 836-3045
Groups this clinician bills Medicare through
Medicare paid, 2024
$603K
85,110 services
Medicare patients, 2024
251
Average age 76
Drug cost, 2024
$293K
1,182 prescriptions
Company payments, 2025
$1,577
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael Yaakobov was code J0174 (injection, lecanemab-irmb, 1 mg), 47,681 times for 12 patients. In total Rafael Yaakobov billed 85,110 services in 63 codes, and Medicare paid $603K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 47,681 | 12 | $1.05 | $50K |
| J1306 Injection, inclisiran, 1 mg | Office | 8,520 | 23 | $9.51 | $81K |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 19 | $17.59 | $24K |
| 96372 Injection Administration | Office | 154 | 79 | $10.75 | $1,656 |
| 96365 Intravenous Infusion, Hydration | Office | 138 | 56 | $48.47 | $6,689 |
| 99213 Office E&M - Established | Office | 121 | 49 | $62.35 | $7,545 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 79 | 16 | $5.45 | $430 |
| 99203 Office E&M - New | Office | 54 | 52 | $83.28 | $4,497 |
| 99214 Office E&M - Established | Office | 50 | 32 | $84.11 | $4,205 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 43 | 23 | $0.94 | $40.62 |
| 36415 Venipuncture Blood Collection | Office | 37 | 29 | $8.65 | $320 |
| 99212 Office E&M - Established | Office | 33 | 12 | $40.83 | $1,347 |
| 94760 Pulmonary | Office | 23 | 22 | $2.38 | $54.81 |
| 87502 Infectious Agent Detection by DNA/RNA | Office | 20 | 18 | $86.14 | $1,723 |
| 87634 Infectious Agent Detection by DNA/RNA | Office | 20 | 18 | $68.80 | $1,376 |
By year: 2022 $221K for 1,309 services; 2023 $1.2M for 33,868 services; 2024 $603K for 85,110 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 37 | 29 | $8.65 | $320 |
| 87502 Infectious Agent Detection by DNA/RNA | 20 | 18 | $86.14 | $1,723 |
| 87634 Infectious Agent Detection by DNA/RNA | 20 | 18 | $68.80 | $1,376 |
| 87635 COVID Specific | 16 | 16 | $50.28 | $804 |
Medicare prescription drug claims, 2024
In 2024, the drug Rafael Yaakobov prescribed most often to Medicare patients was Amlodipine Besylate, with 80 prescriptions and refills. In total Rafael Yaakobov wrote 1,182 Medicare prescriptions that cost $293K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 80 | 132 | 17 | $326 |
| Atorvastatin Calcium Generic | 73 | 109 | 21 | $352 |
| Losartan Potassium Generic | 49 | 71 | Under 11 | $326 |
| Gabapentin Generic | 43 | 43 | Under 11 | $455 |
| Levothyroxine Sodium Generic | 43 | 83 | 12 | $385 |
| Alprazolam Generic | 40 | 40 | Under 11 | $97.75 |
| Simvastatin Generic | 36 | 54 | Under 11 | $218 |
| Pantoprazole Sodium Generic | 31 | 49 | 15 | $321 |
| Metformin Hcl Generic | 28 | 62 | Under 11 | $173 |
| Famotidine Generic | 27 | 29 | 12 | $160 |
| Metoprolol Succinate Generic | 27 | 43 | Under 11 | $242 |
| Rosuvastatin Calcium Generic | 26 | 30 | Under 11 | $93.56 |
| Diclofenac Sodium Generic | 25 | 25 | Under 11 | $27K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 24 | 24 | Under 11 | $236 |
| Oxycodone Hcl Generic | 24 | 24 | Under 11 | $822 |
Brand drugs: - claims; generic drugs: 1,060 claims; opioid claims: 81.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael Yaakobov $1,577 ($1,577 in general payments such as food, travel and fees) from 12 companies. The largest payer was Intra-Sana Laboratories with $810.
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 7 | $810 |
| Alkermes, Inc. ALKS | 5 | $196 |
| Amgen Inc. AMGN | 10 | $153 |
| Abbvie Inc. ABBV | 1 | $124 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $66.03 |
| Novo Nordisk Inc NVO | 2 | $57.21 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $50.71 |
| Lundbeck LLC | 1 | $32.37 |
| Pfizer Inc. PFE | 1 | $27.79 |
| Janssen Biotech, Inc. JNJ | 1 | $23.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.